National Institute on Drug Abuse Keep your Brain Healthy - Keep your Body Healthy
Link to Home Page Link to About NIDA Link to Whats New Link to In the News Link to Publications Link to Spanish Publications Link to Funding Information
Go
Information for - see right links Student Information Index link Parent-Teacher Information Index link Researcher Information Index link


NIDA Home > Publications > Research Monographs >    

Drug Discrimination: Applications to Drug Abuse Research



NIDA Research Monograph, Number 116 [Printed in 1991]


If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.


This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph116.pdf - Drug Discrimination: Applications to Drug Abuse Research (2.1 MB)


Table of Contents

Introduction-----1
Richard A. Glennon

A Historical Perspective on Drug Discrimination-----5
Donald A. Overton

Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs-----25
Richard A. Glennon

Discriminative Stimulus Properties of Amphetamine, Cathinone, and Related Agents-----45
A.J. Goudie

Discriminative Stimulus Effects of Cocaine-----61
William L. Woolverton

Discriminative Stimulus Functions of Cannabinoids/Cannabimimetics-----75
Torbjörn U.C. JŠrbe and Diane A. Mathis

Discriminative Stimulus Properties of Nicotine: Mechanisms of Transduction-----101
John A. Rosecrans and Heidi F. Villanueva

Discriminative Stimulus Properties of Benzodiazepines and Several New Anxiolytics-----117
Richard Young

Distinctive Discriminative Effects of Ethanol-----131
Herbert Barry III

Training Dose: Influences in Opioid Drug Discrimination-----145
Sandra D. Comer, Charles P. France, and James H. Woods

Discriminative Stimulus Properties of Phencyclidine and Other NMDA Antagonists-----163
Robert L. Balster

Discriminative Stimulus Effects of Psychomotor Stimulants and Benzodiazepines in Humans-----181
Chris-Ellyn Johanson

Tolerance to Drugs Acting as Discriminative Stimuli-----197
Alice M. Young

Tolerance: Role of Conditioning Processes-----213
Shepard Siegel

Responding to Drug-Related Stimuli in Humans as a Function of Drug-Use History-----231
Ronald N. Ehrman, Steven J. Robbins, Anna Rose Childress, A. Thomas McLellan. and Charles P. O'Brien

State Dependency as a Mechanism of Central Nervous System Drug Action-----245
Francis C. Colpaert

State-Dependent Learning With Social Drugs-----267
Geoff Lowe

Discriminative Stimulus Effects of Drug Mixtures in Rats-----277
I.P. Stolerman, E.A. Mariathasan, and H. S. Garcha

Application of Drug Discrimination With Drugs of Abuse To Develop New Therapeutic Agents-----307
Theo Frans Meert

Intracranial Stimulation as Reinforcer for Neuropeptide Discrimination-----325
Muriel Gewiss, Christian Heidbreder, and Philippe De Witte

Drug Discrimination Used To Study Drug Withdrawal-----337
M. W. Emmett-Oglesby and G.A. Rowan

Schedule-Induced Self-Injection of Drugs-----359
George Singer

Use of Drug Discrimination in Drug Abuse Research-----369
James B. Appel, Lisa E. Baker, Rita L. Barrett, Julie Broadbent, Elizabeth M. Michael, Elizabeth E. Riddle, and Bette J. Van Groll

Symposium Critique-----399
L.S. Harris



Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment | Print Version
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.